CD19 and leukemia: PROM1 expression was significantly increased in CD19+ bone marrow blasts from mice with CRISPRKMT2A::AFF1 leukemia compared to Cas9-only controls (Figure 1A; P = .02), and correlated strongly with CD133 cell surface protein expression as measured by flow cytometry (Figure 1B).